The company will continue with talks to sell 2,000 patients’ data to biotech companies to further research into a vaccine it has been developing since 2010. The announcement comes in the wake of the company being awarded a second U.S. patent for Favld, a vaccine to treat lymphoma and other cancers, in addition to patents in Australia, Mexico and South Korea, according to CNN MarketWired.
MMRGlobal also owns health IT patents and personal health records in 12 countries, including the U.S. Favld is the company’s first clinical trial series, into which it has invested more than $100 million, according to CNN MarketWired.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
